The effect of early intravenous amino acid supplementation in critically ill patients without acute kidney injury: Protocol for a multicentre, randomised, parallel-controlled trial (the ESSENTIAL trial)
This study protocol was registered with the Chinese Clinical Trial Registry, and the identifier is ChiCTR2100053359 (https://www.chictr.org.cn/hvshowprojectEN.html?id=257327&v=1.7).
Authors
- Weiqin Li (ORCID: https://orcid.org/0000-0002-8483-6264)
- Lu Ke (ORCID: https://orcid.org/0000-0001-8093-5073)
- Gordon S. Doig (ORCID: https://orcid.org/0000-0003-2141-7000)
- Cheng Lv
- Lingliang Zhou
Institutions
- The University of Sydney (AU)
- Nanjing General Hospital of Nanjing Military Command (CN)
- Northern Sydney Local Health District (AU)
- Southeast University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- Critical Care and Resuscitation
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1016/j.ccrj.2024.10.002
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Nanjing University